VitaNova Life Sciences (VNOV) Asset Utilization Ratio (2018 - 2026)

VitaNova Life Sciences has disclosed Asset Utilization Ratio across 6 years of filings, most recently posting 1.38 for Q3 2026.

• Asset Utilization Ratio for Q3 2026 came in at 1.38, up 17.16% year-over-year; the trailing twelve-month figure through Jul 2026 was 1.38 (up 17.16% YoY), and the FY2026 annual result was 1.29, down 16.65% from the prior year.
• Asset Utilization Ratio for Q3 2026 stood at 1.38, up from 1.27 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 5.1 in Q3 2022 and bottomed at 0.53 in Q2 2024.
• Average Asset Utilization Ratio over 5 years is 2.0, with a median of 1.38 recorded in 2026.
• The widest annual swing landed in 2024, when Asset Utilization Ratio plunged 86.26%; it then surged 181.29% in 2025.
• Year by year, Asset Utilization Ratio stood at 3.07 in 2022, then rose by 25.26% to 3.85 in 2023, then slumped by 79.49% to 0.79 in 2024, then jumped by 54.45% to 1.22 in 2025, then advanced by 13.48% to 1.38 in 2026.
• The last three Asset Utilization Ratio figures came in at 1.38 (Q3 2026), 1.27 (Q2 2026), and 1.37 (Q1 2026), per Business Quant data.